We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Homology Medicines Inc
6 own
14 watching
Current Price
$1.5
$-0.03
(-1.96%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
86.22M
52-Week High
4.26
52-Week Low
1.04
Average Volume
0.09M
Dividend Yield
--
P/E Ratio
--
Market Capitalization86.22M52-Week High4.2652-Week Low1.04Average Volume0.09MDividend Yield--P/E Ratio--What does the Homology Medicines Inc do?
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 1/2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; and HMI-202 to treat metachromatic leukodystrophy. Homology Medicines, Inc. was founded in 2015 and is based in Bedford, Massachusetts.
Read More
How much money does Homology Medicines Inc make?
News & Events about Homology Medicines Inc.
Ticker Report
12days ago
Homology Medicines, Inc. (NASDAQ:FIXX Get Rating) has received a consensus rating of Moderate Buy from the ten brokerages that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and six have given a buy ...
Globe Newswire
1month ago
PHILADELPHIA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX) on behalf of the Companys long-term investors. Recently an amended securities fraud complaint was filed against Homology on behalf of ...
Globe Newswire
3 months ago
- Additional Presentation Focused on Use of Single-Molecule, Modified Base Sequencing to Support Vector Design - BEDFORD, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today a presentation on the design of pheEDIT, a Phase 1...
Globe Newswire
4 months ago
PHILADELPHIA, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX) on behalf of the Companys long-term investors. Recently an amended securities fraud complaint was filed against Homology on behalf of ...
Globe Newswire
6 months ago
AAVHSC16 Biodistribution Properties in Preclinical Models Demonstrated Potential for Systemic Delivery of Genetic Medicines to Brain, Heart and Muscle BEDFORD, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the peer-...
Frequently Asked Questions
Frequently Asked Questions
What is Homology Medicines Inc share price today?
Can Indians buy Homology Medicines Inc shares?
How can I buy Homology Medicines Inc shares from India?
Can Fractional shares of Homology Medicines Inc be purchased?
What are the documents required to start investing in Homology Medicines Inc stocks?
What is today’s traded volume of Homology Medicines Inc?
What is today’s market capitalisation of Homology Medicines Inc?
What is the 52-Week High and Low Range of Homology Medicines Inc?
What percentage is Homology Medicines Inc down from its 52-Week High?
What percentage is Homology Medicines Inc up from its 52-Week Low?
Current Price
$1.5
$-0.03
(-1.96%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.